All News

Public policies to increase compliance with community mitigation strategies may be effective in decreasing community mobility.

Today we’re thanking Andrea and Ann-Marie Idusuyi, 2 sisters working hard on the frontlines of the COVID-19 pandemic.

Remdesivir is not yet licensed or approved anywhere internationally and has not been demonstrated to be safe or effective for the treatment of COVID-19.

Researchers investigated the presence of coronaviruses in the bat population due to an understanding that coronaviruses can spread following a spillover from animals.

Chloroquine, hydroxychloroquine, and azithromycin are currently being evaluated as potential treatments for COVID-19, despite limited evidence to support the drugs’ efficacy.

A new study reports valuable new grip strength metrics that provide health care practitioners with an easy-to-perform, time-efficient screening tool for type 2 diabetes.

The American Lung Association (ALA) has started a $25M initiative to address the coronavirus disease 2019 (COVID-19) pandemic and other future respiratory virus pandemics.

The findings showed that non-SCD congenital anemia diagnosis was associated with a higher risk of HIV acquisition compared with SCD, according to the study authors.

A study based in Brazil has been halted early for safety reasons after patients with coronavirus disease 2019 taking a higher dose of chloroquine developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia.

Approximately 1 in 40 postmenopausal women diagnosed with breast cancer before the age of 65 had a mutation linked to cancer in the BRCA1 or BRCA2 gene, according to an analysis of data from the Women’s Health Initiative (WHI).

The kinase inhibitor selumetinib was approved for the treatment of pediatric patients aged 2 years and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.

A new test developed for the coronavirus disease 2019 (COVID-19) that uses saliva has been approved by the FDA, according to Rutgers University.

Today we’re celebrating Seth Heldenbrand, PharmD, dean of experiential education at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy.

Providers with access to COVID-19 tests have reported false-negative results for some patients, raising concerns about the limitations of tests as a source of reliable information.

Why is spironolactone prescribed by a dermatologist for a young woman with no indications of edema?

Pain is the most common reason patients seek medical marijuana, yet patients' resulting consumption patterns of marijuana when treating pain may also have an effect on their health.

There have been reports of patients with COVID-19 having ST-segment elevation (STE) and, even after invasive coronary angiography, continuing to show no signs of COVID-19.

Although chloroquine and hydroxychloroquine have been touted as potential treatments for COVID-19, physicians in Italy have warned that the global supply may not be able to keep up with demand.

Purdue University’s College of Pharmacy is granting early graduation to 144 students to help cover a potential shortage of pharmacists during the coronavirus disease 2019 pandemic.

The objective of the study was to determine whether there was an association between PrEP use and decreases in HIV diagnoses.

Individuals with type 1 diabetes, specifically those with poor glycemic control, are at an greater risk for cardiovascular disease than the general population, according to a study by Joslin Research.

Although testing and vaccination for the human papillomavirus have decreased the number of cervical cancer deaths, the disease remains the fourth most common cancer type in women.

Demcizumab is a DLL4-targeted lgG2 humanized monoclonal antibody and a potent inhibitor of the Notch pathway.

COA released a statement explaining that it fundamentally opposes home infusion of chemotherapy, cancer immunotherapy, and cancer treatment supportive drugs due to concerns regarding the safety of patients in such an environment.

Derek Angus, MD, MPH and his collaborators had developed a platform called REMAP-Community Acquired Pneumonia (REMAP-CAP), which was designed to find optimal treatment for severe pneumonia both in non-pandemic and pandemic settings.

Every pharmacy within the Guardian Pharmacy Service network has their own disaster contingency plan in place so that they are supported in an emergency, such as the coronavirus disease 2019 pandemic.

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

Today we’re celebrating the work of Andrea Torres, CPhT, who works at Axtell Pharmacy in Pilot Point, Texas.

A case study of a patient in Wuhan, China suggests that the immunosuppressant tocilizumab may be an effective coronavirus disease 2019 treatment for patients with multiple myeloma and other blood cancers.

By mining a vast trove of genetic data, researchers are enhancing physicians’ ability to treat cancer, predict patient outcomes, and determine which treatment will work best for individual patients.